ACHC
Acadia Healthcare·NASDAQ
--
--(--)
--
--(--)
7.90 / 10
Outperform
Analyst sentiment is positive, with 50% Strong Buy, 16.7% Buy and 33.3% Neutral across six views; Barclays raised the price target to $20. Fund‑flow scoring is 7.7/10 (good), showing overall inflow ratio ~0.48 but negative trends in most size segments, except small inflows.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
17%
Hold
0%
Sell
0%
Strong Sell
0%
Andrew MokNeutral
Date2026-03-03
InstitutionBarclays
Times predicted9
Historical Win Rate44.4%
Ben HendrixBuy
Jason CassorlaStrong Buy
Ryan LangstonStrong Buy
Whit MayoNeutral
What is the market sentiment for ACHC?
- ACHC holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.90/10 (Outperform).
